Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

CEL-SCI Corporation

TRADE

AMEX: CVMHealthcare / Biotechnology / USA
2.94+0.11+3.89%Vol 25 9371Y Perf 64.97%
Nov 21st, 2018 10:15
BID2.94 ASK0.00
Open2.90 Previous Close2.83
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
Hold 3.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-33 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-24 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/-23 
Income Ranking
 —    -
Market Cap (mil)83 
Earnings Rating
Buy
Price Range Ratio 52wk %
58.56 
Earnings Date
4th Jan 2019

Today's Price Range

2.902.97

 

52wk Range

0.824.44

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-19.60%
3 Months
74.69%
6 Months
0.00%
1 Year
64.97%
3 Years
-76.42%
5 Years
-86.02%

Quotes

Name / TickerPriceChg.Chg.%
CVM2.940.11003.89
AAPL177.700.72000.41
GOOG1 041.1815.42001.50
MSFT103.201.49001.46
XOM77.810.84001.09
WFC52.850.31000.59
JNJ142.88-3.5700-2.44
FB136.033.60002.72
GE7.840.19002.48
JPM108.940.49000.45
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.30
Current Ratio 0.40
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -10.10
Leverage Ratio -7.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-4 608.20
EBITDA Margin-4 433.20
Pre-tax Profit Margin-12 256.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.93
PS Ratios 243.12
Price to Cash Flow -
Price to Free Cash Flow -9.30
Cash Flow Per Share -0.94
Price to Tangible Book-57.54
Book Value per Share-0.04
Enterprise Value (in ths.)96 088
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-759.92
ROE last 12 Months 669.65
Return on Assets (5Y Avg) -136.64
ROA last 12 Months -145.78
Return on Capital (5Y Avg) -
ROC last 12 Months -1 241.85
Return on invested Capital Q -1 242.64
Return on invested Capital Y-
Assets Turnover0.00
Receivables Turnover1.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)350
Revenue per Share 0.01
Revenue Growth 3 Years -33.07
Revenue Growth 5 Years -2.10
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.36-
Q02 2018--0.31-
Q01 2018--0.53-
Q04 2017--0.58-
Q04 2016--0.25-
Q03 2016--0.75-
Q02 2016--0.07-
Q01 2016-0.02-
Earnings Per EndEstimateRevision %Trend
9/2018 FY-0.950.00-
9/2018 FY-1.04--
----
----
Next Report Date4th Jan 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume25 937
Shares Outstanding (in ths.)28 270
Trades Count58
Dollar Volume74 849
Avg. Volume583 005
Avg. Weekly Volume193 001
Avg. Monthly Volume259 080
Avg. Quarterly Volume1 026 949

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

77%23%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x